Mitochondrial cytochrome c-mediated apoptosis pathway

The mitochondrial cytochrome c-mediated apoptosis pathway, also known as the intrinsic apoptosis pathway, is a canonical cell death signaling route activated by various cellular stresses such as DNA damage, oxidative stress, and growth factor deprivation[7][1][5]. Upon activation, pro-apoptotic Bcl-2 family proteins (Bax, Bak) permeabilize the mitochondrial outer membrane, leading to the release of cytochrome c into the cytosol[1][2][3][5][6]. Cytochrome c binds to Apaf-1, forming the apoptosome, which recruits and activates caspase-9, and subsequently activates effector caspases like caspase-3, executing programmed cell death[1][5][7]. This pathway is distinct from the extrinsic (death receptor–mediated) apoptosis route and is crucial for development, tissue homeostasis, as well as the elimination of damaged or potentially harmful cells[7]. Dysregulation can result in cancer, degenerative disorders, or impaired immune function[7][5]. The pathway itself is not a single molecular drug target but a collection of interacting proteins, several of which (e.g., Bcl-2) are targets for anticancer drugs like venetoclax. Cytochrome c release into the cytoplasm, and sometimes extracellular space, serves as a reliable biomarker for apoptosis in research and potentially clinical monitoring[2][5]. Inhibition or inappropriate activation of this pathway is a key concern for drug safety and antitumor efficacy.

Other names

Intrinsic apoptosis pathwayMitochondrial pathway of apoptosisMitochondrial cytochrome c release pathwayCytochrome c-mediated apoptosis

Inducing mitochondrial outer membrane permeabilization (drugs targeting Bcl-2/Bcl-xL/BAX/BAK proteins); promoting or inhibiting cytochrome c release from mitochondria; caspase activation via apoptosome assembly.